GUIDELINES - The Endocrine Society

Authors: John W. Funder, Robert M. Carey, Carlos Fardella, Celso E. Gomez-Sanchez, Franco Mantero, MichaelStowasser, William F. Young Jr, Jr., and Victor M. MontoriAffiliations: Prince Henry's Henry’s Institute of Medical Research (J.W.F.), Clayton; Australia; University of VirginiaHealth System (R.M.C.), Charlottesville, Virginia; Facultad de Medicina Pontificia Universidad Católica deChile (C.F.), Santiago; Chile; G.V. (Sonny) Montgomery VA Medical Center (C.E.G-S.), Jackson, Mississippi;University of Padova (F.M.), Padua; Italy; University of Queensland (M.S.), Brisbane; Australia; and Mayo Clinic(W.F.Y., V.M.M.), Rochester, Minnesota.Co-Sponsoring Associations: European Society of Endocrinology, European Society of Hypertension,International Society of Endocrinology, International Society of Hypertension, The Japanese Society ofHypertensionDisclaimer Statement: Clinical Practice Guidelines are developed to be of assistance to endocrinologists byproviding guidance and recommendations for particular areas of practice. The Guidelines should not be consideredinclusive of all proper approaches or methods, or exclusive of others. The Guidelines cannot guarantee any specificoutcome, nor do they establish a standard of care. The Guidelines are not intended to dictate the treatment of aparticular patient. Treatment decisions must be made based on the independent judgment of health care providersand each patient's individual circumstances.The Endocrine Society makes no warranty, express or implied, regarding the Guidelines and specificallyexcludes any warranties of merchantability and fitness for a particular use or purpose. The Society shall not beliable for direct, indirect, special, incidental, or consequential damages related to the use of the informationcontained herein.First published in the Journal of Clinical Endocrinology & Metabolism, September 2008, 93(9):3266–3281© The Endocrine Society, 2008